HZNP IE00BQPVQZ61

Report

Real-time Estimate Cboe BZX - 11:25:48 2023-02-03 am EST
110.21	USD		+0.38%

02/01	Amgen Shares Slip 4.1% Following Decline in 4Q Profit, Revenue	DJ
02/01	Amgen Fourth-Quarter Results Decline on Foreign-Exchange Headwinds, Issues Full-Year Outlook	MT
01/31	Amgen 4Q Profit Declines, Revenue Ticks Down Slightly	DJ

Upwardly Revised Q3 GDP Ahead of Powell's Speech Lifts US Equities Higher Premarket

11/30/2022 | 09:00am EST

Stocks mentioned in the article	Change	Last	1st jan.
AMGEN INC.	-0.81%	244.52	-6.13%
AST SPACEMOBILE, INC.	4.09%	6.1499	21.78%
BRENT OIL	0.62%	82.68	-3.41%
DAX	-0.34%	15455.6	11.39%
DOW JONES INDUSTRIAL	0.22%	34124.7	2.74%
FTSE 100	0.95%	7896.79	4.94%
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	0.37%	110.185	-3.52%
MSCI UNITED KINGDOM (STRD)	0.30%	1146.19	6.35%
NASDAQ COMPOSITE	-0.06%	12187.42	16.57%
NETAPP, INC.	-0.85%	68.5	14.97%
NIKKEI 225	0.39%	27509.46	5.01%
PETCO HEALTH AND WELLNESS COMPANY, INC.	-0.08%	12.27	29.43%
S&P GSCI BRENT CRUDE INDEX	-0.11%	697.788	-4.35%
S&P UNITED KINGDOM (PDS)	1.08%	1602.26	4.34%
S&P/CITIC 300 INDEX	-0.98%	3789.07	8.29%
S&P/CITIC 50 INDEX	-1.31%	3647.09	7.84%
SANOFI	-1.91%	85.19	-3.42%
TITAN MACHINERY INC.	1.54%	45.6	13.04%
WTI	0.82%	76.686	-4.63%

All news about HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

02/01	Amgen Shares Slip 4.1% Following Decline in 4Q Profit, Revenue	DJ
02/01	Amgen Fourth-Quarter Results Decline on Foreign-Exchange Headwinds, Issues Full-Year Ou..	MT
01/31	Amgen 4Q Profit Declines, Revenue Ticks Down Slightly	DJ
01/31	Horizon Therapeutics Public Ltd Co : Other Events (form 8-K)	AQ
01/31	Amgen revenue falls slightly as Lilly COVID deal contributes less	RE
01/30	Rule 15 Announcement, Horizon Therapeutics plc	AQ
01/30	Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2022 Financial Results..	BU
01/27	Rule 15 (c) Announcement – Horizon Therapeutics plc	BU
01/26	Warren tells FTC she is "particularly concerned" about Amgen and Indivior deals	RE
01/25	Horizon Therapeutics Investor Alert : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..	BU

Analyst Recommendations on HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

02/01	Amgen Shares Slip 4.1% Following Decline in 4Q Profit, Revenue	DJ
2022	UBS Adjusts Horizon Therapeutics Price Target to $116.50 From $76, Maintains Neutral Ra..	MT
2022	BMO Capital Downgrades Horizon Therapeutics to Market Perform From Outperform With $11..	MT

Financials (USD)

Chart HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

Duration : Period :

Technical analysis trends HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

	Short Term	Mid-Term	Long Term
Trends	Bearish	Bullish	Neutral

Income Statement Evolution

More Financials

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Timothy P. Walbert	Chairman, President & Chief Executive Officer
Aaron L. Cox	Chief Financial Officer & Executive Vice President
Jeffrey W. Sherman	CMO, Executive VP-Development & Regulatory Affairs
Michael A. DesJardin	Executive VP-Technical Operations & Quality
Jeffrey D. Kent	Executive VP-Medical Affairs & Outcomes Research

Sector and Competitors

		1st jan.	Capi. (M$)
	HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	-3.52%	25 075

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY